This protocol describes the analysis of human hepatocarcinoma cells (Hep G2) for lipid peroxidation products such as malondialdehyde (MDA), following treatment with nanoparticle formulations, as part of the in vitro NCL preclinical characterization cascade (1-2).

• NCL_Method_GTA-4.pdf(PDF | 722 KB)

Researchers should cite this work as follows:

• Stephan Stern, Timothy Potter, Barry Neun (2020). NCL Method GTA-4. (Version 2.0b). NCI Hub. doi:10.17917/H65D-SJ70

  BibTex | EndNote

1. lipid peroxidation
2. Nanoparticles

The publication is part of the series below:

• Hints 5 Cycle 2

  Data collection for Cycle 2 of HINTS 5 began in January 2018 and concluded in May 2018.

• Untitled Draft (16sdsdsds

  drtrdsf

• Hints 5 Cycle 2.1

  This is the Hints 5 Cycle 2

• HINTS 5 Cycle 2.2

  This is the 11/27 version

• HINTS 5 Cycle 2 11.27

  this is for the hints 5 cycle 2 11/27

• HINTS 5 Cycle 2

  HINTS 5 Cycle 2 data and supporting documents can be found here.